CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 2 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-22 | Stuart Iain Chief Scientific Officer | Grant or award | +29,213 | 100,778 | ||
| 2021-02-22 | Stuart Iain Chief Scientific Officer | Grant or award · Stock Options | +68,162 | 68,162 | ||
| 2021-02-22 | Saik Andrew Chief Financial Officer | Grant or award | +29,213 | 114,213 | ||
| 2021-02-22 | Saik Andrew Chief Financial Officer | Grant or award · Stock Options | +68,162 | 68,162 | ||
| 2021-02-22 | Harsch Mutya Chief Legal Officer and GC | Grant or award | +29,213 | 110,638 | ||
| 2021-02-22 | Harsch Mutya Chief Legal Officer and GC | Grant or award · Stock Options | +68,162 | 68,162 | ||
| 2021-02-22 | Domzalski David President and CEO | Grant or award | +153,750 | 479,833 | ||
| 2021-02-22 | Domzalski David President and CEO | Grant or award · Stock Options | +358,750 | 358,750 | ||
| 2021-01-28 | PERCEPTIVE ADVISORS LLC 10% owner | Purchase | +4,219,409 | $2.37 | $10.0M | 27,095,819 |
| 2020-12-31 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −1,541 | $1.58 | $2K | 357,181 |
| 2020-12-31 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −2,378 | $1.58 | $4K | 286,262 |
| 2020-12-31 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,822 | $1.58 | $3K | 325,703 |
| 2020-12-31 | Domzalski David President and CEO | Shares withheld for taxes | −9,656 | $1.58 | $15K | 1,304,334 |
| 2020-12-03 | LEPORE PATRICK G Director | Purchase | +50,000 | $1.71 | $85K | 50,000 |
| 2020-11-30 | Wiley Matthew T. Chief Commercial Officer | Grant or award | +7,838 | $1.45 | $11K | 358,722 |
| 2020-11-30 | Harsch Mutya Chief Legal Officer and GC | Grant or award | +10,460 | $1.45 | $15K | 327,525 |
| 2020-11-30 | Domzalski David President and CEO | Grant or award | +4,263 | $1.45 | $6K | 1,313,990 |
| 2020-09-30 | Wiley Matthew T. Chief Commercial Officer | Shares withheld for taxes | −1,541 | $1.66 | $3K | 350,884 |
| 2020-09-30 | Stuart Iain Chief Scientific Officer | Shares withheld for taxes | −2,378 | $1.66 | $4K | 288,640 |
| 2020-09-30 | Harsch Mutya Chief Legal Officer and GC | Shares withheld for taxes | −1,822 | $1.66 | $3K | 317,065 |
Page 11 of 22 · 425 trades